U S Veterinary Diagnostics Market
Market Size in USD Billion
CAGR :
% 
USD
3.31 Billion
USD
6.99 Billion
2022
2030
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 3.31 Billion |
 Market Size (Forecast Year) |
USD 6.99 Billion |
 CAGR |
% |
| Major Markets Players |
|
U.S. Veterinary Diagnostics Market, By Product (Consumables, Reagents & Kits, Instruments & Devices), Species (Bovine, Camelid, Caprine, Canine & Feline, Equine, Ovine, Porcine, Avian, Others), Testing Category (Analytical Services, Diagnostic Imaging, Bacteriology, Pathology, Molecular Diagnostic, Immunoassays, Parasitology, Serology, Virology), Disease Type (Infectious Diseases, Non-Infectious Diseases, Hereditary, Congenital, General Ailments, Structural & Functional Diseases), End User (Hospitals, Specialty Clinics, Academic & Research Institutes, and Others) – Industry Trends and Forecast to 2030.
U.S. Veterinary Diagnostics Market Analysis and Size
Veterinary diagnostics are considered an important part of the management and prevention of outbreaks of diseases among animals. The increase in the importance of the prevention and control of zoonotic diseases is accelerating the market's growth. Moreover, veterinarians have been slowly increasing the frequency of diagnostic testing. Furthermore, several diagnostics advancements and the increasing acceptance of innovative techniques in most laboratories are pushing market growth.
Data Bridge Market Research analyses a growth rate in the veterinary diagnostics market in the forecast period 2023-2030. The expected CAGR of the veterinary diagnostics market tends to be around 9.80% in the mentioned forecast period. The market was valued at USD 3.31 billion in 2022 and would grow to USD 6.99 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
U.S. Veterinary Diagnostics Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Consumables, Reagents & Kits, Instruments & Devices), Species (Bovine, Camelid, Caprine, Canine & Feline, Equine, Ovine, Porcine, Avian, Others), Testing Category (Analytical Services, Diagnostic Imaging, Bacteriology, Pathology, Molecular Diagnostic, Immunoassays, Parasitology, Serology, Virology), Disease Type (Infectious Diseases, Non-Infectious Diseases, Hereditary, Congenital, General Ailments, Structural & Functional Diseases), End User (Hospitals, Specialty Clinics, Academic & Research Institutes, and Others) |
|
Market Players Covered |
General Electric (U.S.), BIOMÉRIEUX (France), Heska Corporation (U.S.), IDEXX (U.S.), Neogen Corporation (U.S.), INDICAL BIOSCIENCE GmbH (Germany), Randox Laboratories Ltd. (U.K.), Thermo Fisher Scientific (U.S.), Virbac (France), Zoetis (U.S.), Creative Diagnostics (U.S.), DRG INSTRUMENTS GMBH (Germany), Chembio Diagnostic Systems, Inc. (U.S.), Eurofins Scientific (Luxembourg), Zoetis Services LLC (U.S.), Agrolabo S.p.A. (Italy), Abbott (U.S.), Danaher (U.S.) |
|
Market Opportunities |
|
Market Definition
Veterinary diagnostics is referred to the tools that are widely used in the diagnosis of animal diseases that are caused due to microorganisms, which include fungi, bacteria, viruses, and pathogens, among others. These diagnostics tools are increasingly used for detecting disease, testing the presence of disease-causing agents, observing disease progression, and providing optimal therapeutics accordingly.
U.S. Veterinary Diagnostics Market Dynamics
Drivers
- Increasing Advancements and Development of Techniques
Several diagnostics advancements and the increasing acceptance of innovative techniques in most laboratories are boosting market growth. For instance, FORCE Technology launched a new subsidiary, AeroCollect A/S, in 2021. AeroCollect technology with simple air samples provides a picture of the diseases. This is a huge revolution in animal diagnostics which is developed in Denmark by the GTS institute FORCE Technology. This technology is presently used in the poultry, swine, and mink industries. Thus, this factor boosts market growth.
- Increasing Adoption of Diagnostic Testing by Veterinarians
Veterinarians have been slowly increasing the frequency of diagnostic testing. This trend became more popular during the COVID-19 when hospitals had to focus mainly on essential pet services. Persistent growth in the population of pets and the higher penetration of veterinary diagnostic products at veterinary clinics further increase the market growth. For instance, IDEXX showed huge utilization of diagnostics, which witnessed a 21% surge in same-store diagnostic revenue per practice, and a 15% surge in same-store veterinary clinic revenue in its Q1 2021 earning call. Thus, it boosts the market growth.
Opportunities
- Rising demand for Point-Of-Care Diagnostics
Growing demand for point-of-care diagnostics is anticipated to boost market growth. It provides quick results for clinical tests and can be directly assessed to save time. In 2019, around 26,000 veterinary hospitals and clinics in the U.S. were set, and more than 80% of them offered point-of-care testing. Furthermore, DCN Dx acquired PortaScience, Inc., a point-of-care diagnostics development corporation, in June 2021. With this acquisition, DCN Dx extended its capabilities for veterinary, healthcare, and consumer markets. Thus, this boosts market growth.
- Rising Concern Among Pet Owners
The growing concern of pet owners led to a regular diagnosis of glucose levels, increasing the market for glucose monitors. The increasing pork consumption and demand for better diagnostic procedures are leading the market growth. For instance, MatMaCorp launched MYRTA which is a hand-held real-time PCR device for over-the-counter and point-of-care molecular diagnostics solutions for human and animal health, in 2021. This system could also be used in veterinary health to detect porcine reproductive and respiratory syndrome viruses. Thus, this factor boosts market growth.
Restraints/Challenges
- High Cost of Animal Diagnostics
Various diagnostic tools are expensive and cannot be afforded by underdeveloped countries. Much expenses of pet care lead to the deterioration of the market growth. Thus, these factors restrict market growth.
This veterinary diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
U.S. Veterinary Diagnostics Market Scope
The veterinary diagnostics market is segmented on the basis of product, species, testing category, disease type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Reagents & Kits
- Instruments & Devices
Species
- Bovine
- Camelid
- Caprine
- Canine & Feline
- Equine
- Ovine
- Porcine
- Avian
- Others
Testing Category
- Analytical Services
- Diagnostic Imaging
- Bacteriology
- Pathology
- Molecular Diagnostic
- Immunoassays
- Parasitology
- Serology
- Virology
Disease Type
- Infectious Diseases
- Non Infectious Diseases
- Heridatary
- Congenital
- General Ailments
- Structural & Functional Diseases
End User
- Hospitals
- Specialty Clinics
- Academic & Research Institutes
- Others
Competitive Landscape and U.S. Veterinary Diagnostics Market Share Analysis
The veterinary diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, U.S. presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to veterinary diagnostics market.
Key players operating in the veterinary diagnostics market include:
- General Electric (U.S.)
- BIOMÉRIEUX (France)
- Heska Corporation (U.S.)
- IDEXX (U.S.)
- Neogen Corporation (U.S.)
- INDICAL BIOSCIENCE GmbH (Germany)
- Randox Laboratories Ltd. (U.K.)
- Thermo Fisher Scientific (U.S.)
- Virbac (France), Zoetis (U.S.)
- Creative Diagnostics (U.S.)
- DRG INSTRUMENTS GMBH (Germany)
- Chembio Diagnostic Systems, Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- Zoetis Services LLC (U.S.)
- Agrolabo S.p.A. (Italy)
- Abbott (U.S.)
- Danaher (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF U.S. VETERINARY DIAGNOSTICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL XX SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 U.S. VETERINARY DIAGNOSTICS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 INNOVATION STRATEGIES AND METHODOLOGIES
10.3 RISK ASSESSMENT AND MITIGATION
10.4 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 VALUE CHAIN ANALYSIS
12.1 ECONOMIC DEVELOPMENT
13 U.S. VETERINARY DIAGNOSTICS MARKET, BY PRODUCT
13.1 OVERVIEW
13.2 INTRUMENTS & DEVICES
13.2.1 BY TYPE
13.2.1.1. IMAGING DEVICES
13.2.1.1.1. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
13.2.1.1.2. X-RAY IMAGING (RADIOGRAPHY)
13.2.1.1.3. ULTRASOUND
13.2.1.1.4. COMPUTED TOMOGRAPHY
13.2.1.1.5. MAGNETIC RESONANCE IMAGING
13.2.1.1.6. OTHERS
13.2.1.2. LABORATORY INSTRUMENTS
13.2.1.2.1. HEMATOLOGY ANALYZERS
13.2.1.2.2. CHEMISTRY ANALYZERS
13.2.1.2.3. COAGULATION ANALYZERS
13.2.1.2.4. REFRACTOMETER
13.2.1.2.5. URINALYSIS EQUIPMENT
13.2.1.3. POINT-OF-CARE INSTRUMENTS
13.2.1.3.1. LATERAL FLOW POCT
13.2.1.3.2. MOLECULAR POCT
13.2.1.3.3. OTHERS
13.2.1.4. OTHERS
13.2.2 BY MODALITY
13.2.2.1. BENCHTOP
13.2.2.2. STANDALONE
13.2.2.3. PORTABLE
13.2.3 BY FUNCTION
13.2.3.1. AUTOMATED
13.2.3.2. SEMIAUTOMATED
13.2.3.3. MANUAL
13.3 REAGENTS & CONSUMBALES
13.3.1 KITS
13.3.1.1. ELISA KITS
13.3.1.1.1. PCR KITS
13.3.1.1.2. MULTPLEX KITS
13.3.1.1.3. RAPID TEST KITS
13.3.1.1.4. SAMPLE PREPARATION KITSISOLATION AND EXTRACTION KITS
13.3.1.1.5. OTHERS
13.3.2 REAGENTS
13.3.2.1. IMMUNOFLUORESCENCE REAGENTS
13.3.2.1.1. INDIRECT IMMUNOFLUORESCENCE
13.3.2.1.2. DIRECT IMMUNOFLUORESCENCE
13.3.2.2. COOMBS REAGENTS
13.3.2.3. NUCLEIC ACID EXTRACTION REAGENTS
13.3.2.4. OTHERS REAGENTS
13.3.3 CASSETTE
13.3.4 STRIPS
13.3.5 PANEL
13.3.6 CONTROL STANDARDS
13.3.7 PROBES AND PRIMER
13.3.8 MEDIA
13.3.9 OTHERS CONSUBAME AND ACCESSORIES
14 U.S. VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY
14.1 OVERVIEW
14.2 IMMUNODIAGNOSTICS
14.2.1 BY TYPE
14.2.1.1. ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS)
14.2.1.2. RADIOIMMUNOASSAYS
14.2.1.3. IMMUNOFLUORESCENCE
14.2.1.4. OTHERS
14.2.2 BY ANIMAL TYPE
14.2.2.1. COMPANION ANIMAL
14.2.2.2. LIVESTOCK ANIMALS
14.3 MOLECULAR DIAGNOSTICS
14.3.1 BY TYPE
14.3.1.1. POLYMERASE CHAIN REACTION (PCR)
14.3.1.1.1. SPCR
14.3.1.1.2. QPCR
14.3.1.1.3. RT-PCR
14.3.1.1.4. MULTIPLEX PCR
14.3.1.1.5. OTHERS
14.3.1.2. MICROARRAY
14.3.1.3. DNA SEQUENCING
14.3.1.3.1. SANGER SEQUENCING
14.3.1.3.2. FRAGMENT SEQUENCING
14.3.1.3.3. NEXT-GENERATION SEQUENCING (NGS)
14.3.1.3.4. OTHERS
14.3.1.4. OTHERS
14.3.2 BY ANIMAL TYPE
14.3.2.1. COMPANION ANIMAL
14.3.2.2. LIVESTOCK ANIMALS
14.4 HAEMATOLOGY
14.4.1 BY ANIMAL TYPE
14.4.1.1. COMPANION ANIMAL
14.4.1.2. LIVESTOCK ANIMALS
14.5 URINALYSIS
14.5.1 BY ANIMAL TYPE
14.5.1.1. COMPANION ANIMAL
14.5.1.2. LIVESTOCK ANIMALS
14.6 CLINICAL BIOCHEMISTRY
14.6.1 BY ANIMAL TYPE
14.6.1.1. COMPANION ANIMAL
14.6.1.2. LIVESTOCK ANIMALS
14.7 IMAGING
14.7.1 BY ANIMAL TYPE
14.7.1.1. COMPANION ANIMAL
14.7.1.2. LIVESTOCK ANIMALS
14.8 OTHERS
15 GLOBAL VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE
15.1 OVERVIEW
15.2 COMPANION ANIMALS
15.2.1 DOGS
15.2.2 CATS
15.2.3 HORSES
15.2.4 OTHER
15.3 LIVESTOCK ANIMAL
15.3.1 CATTLE
15.3.2 SWINE
15.3.3 POULTRY
15.3.4 OTHER
16 U.S. VETERINARY DIAGNOSTICS MARKET, BY DISEASE TYPE
16.1 OVERVIEW
16.2 INFECTIOUS DISEASES
16.2.1 BACTERIAL
16.2.1.1. CANINE PYOMETRA
16.2.1.2. ACTINOBACILLOSIS
16.2.1.3. ACTINOMYCOSIS
16.2.1.4. OTHERS
16.2.2 VIRAL
16.2.2.1. CANINE PARVOVIRUS
16.2.2.2. BOVINE VIRAL DIARRHEA (BVD)
16.2.2.3. OTHERS
16.2.3 FUNGAL
16.2.3.1. RINGWORM
16.2.3.2. CRYPTOCOCCOSIS
16.2.4 OTHERS
16.3 NON-INFECTIOUS DISEASES
16.3.1 CUSHING'S DISEASE
16.3.2 DIABETES MELLITUS
16.3.3 RENAL (KIDNEY) DISEASE
16.3.4 OTHERS
16.4 HEREDITARY
16.4.1 CANCER
16.4.2 HEART DISEASE
16.4.3 SKIN COMPLAINTS
16.4.4 EPILEPSY
16.4.5 HIP DYSPLASIA
16.4.6 OTHERS
16.5 OTHERS
17 U.S. VETERINARY DIAGNOSTICS MARKET, BY TESTING LOCATION
17.1 OVERVIEW
17.2 LABORATORIES BASED TESTING
17.3 POINT OF CARE TESTING
18 U.S. VETERINARY DIAGNOSTICS MARKET, BY END USER
18.1 OVERVIEW
18.2 VETERINARY HOSPITAL
18.3 VETERINARY CLINICS
18.4 ANIAML FARMS AND HUSBANDRY
18.5 PET SHOPS
18.6 ACAMEIC AND RESEARCH LABORATORIES
18.7 OTHER
19 U.S. VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
19.1 OVERVIEW
19.2 DIRECT TENDER
19.3 RETAIL SALES
19.4 ONLINE SALES
19.5 OTHERS
20 U.S. VETERINARY DIAGNOSTICS MARKET, BY GEOGRAPHY
U.S. VETERINARY DIAGNOSTICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
21 U.S. VETERINARY DIAGNOSTICS MARKET, COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: U.S.
21.2 MERGERS & ACQUISITIONS
21.3 NEW PRODUCT DEVELOPMENT & APPROVALS
21.4 EXPANSIONS
21.5 REGULATORY CHANGES
21.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
22 U.S. VETERINARY DIAGNOSTICS MARKET, SWOT ANALYSIS
23 U.S. VETERINARY DIAGNOSTICS MARKET, COMPANY PROFILE
23.1 IDEXX
23.1.1 COMPANY OVERVIEW
23.1.2 REVENUE ANALYSIS
23.1.3 GEOGRAPHIC PRESENCE
23.1.4 PRODUCT PORTFOLIO
23.1.5 RECENT DEVELOPMENTS
23.2 ZOETIS SERVICES LLC
23.2.1 COMPANY OVERVIEW
23.2.2 REVENUE ANALYSIS
23.2.3 GEOGRAPHIC PRESENCE
23.2.4 PRODUCT PORTFOLIO
23.2.5 RECENT DEVELOPMENTS
23.3 THERMO FISHER SCIENTIFIC INC
23.3.1 COMPANY OVERVIEW
23.3.2 REVENUE ANALYSIS
23.3.3 GEOGRAPHIC PRESENCE
23.3.4 PRODUCT PORTFOLIO
23.3.5 RECENT DEVELOPMENTS
23.4 HESKA CORPORATION
23.4.1 COMPANY OVERVIEW
23.4.2 REVENUE ANALYSIS
23.4.3 GEOGRAPHIC PRESENCE
23.4.4 PRODUCT PORTFOLIO
23.4.5 RECENT DEVELOPMENTS
23.5 NEOGEN CORPORATION
23.5.1 COMPANY OVERVIEW
23.5.2 REVENUE ANALYSIS
23.5.3 GEOGRAPHIC PRESENCE
23.5.4 PRODUCT PORTFOLIO
23.5.5 RECENT DEVELOPMENTS
23.6 BIO-RAD LABORATORIES, INC.
23.6.1 COMPANY OVERVIEW
23.6.2 GEOGRAPHIC PRESENCE
23.6.3 PRODUCT PORTFOLIO
23.6.4 RECENT DEVELOPMENTS
23.7 VIRBAC
23.7.1 COMPANY OVERVIEW
23.7.2 REVENUE ANALYSIS
23.7.3 GEOGRAPHIC PRESENCE
23.7.4 PRODUCT PORTFOLIO
23.7.5 RECENT DEVELOPMENTS
23.8 BIONOTE USA INC.
23.8.1 COMPANY OVERVIEW
23.8.2 REVENUE ANALYSIS
23.8.3 GEOGRAPHIC PRESENCE
23.8.4 PRODUCT PORTFOLIO
23.8.5 RECENT DEVELOPMENTS
23.9 EUROFINS SCIENTIFIC.
23.9.1 COMPANY OVERVIEW
23.9.2 REVENUE ANALYSIS
23.9.3 GEOGRAPHIC PRESENCE
23.9.4 PRODUCT PORTFOLIO
23.9.5 RECENT DEVELOPMENTS
23.1 VMRD, INC.
23.10.1 COMPANY OVERVIEW
23.10.2 GEOGRAPHIC PRESENCE
23.10.3 PRODUCT PORTFOLIO
23.10.4 RECENT DEVELOPMENTS
23.11 FUJIFILM
23.11.1 COMPANY OVERVIEW
23.11.2 REVENUE ANALYSIS
23.11.3 GEOGRAPHIC PRESENCE
23.11.4 PRODUCT PORTFOLIO
23.11.5 RECENT DEVELOPMENTS
23.12 MINDRAY ANIMAL MEDICAL TECHNOLOGY NORTH AMERICA CO., LTD.
23.12.1 COMPANY OVERVIEW
23.12.2 REVENUE ANALYSIS
23.12.3 GEOGRAPHIC PRESENCE
23.12.4 PRODUCT PORTFOLIO
23.12.5 RECENT DEVELOPMENTS
23.13 ESAOTE SPA
23.13.1 COMPANY OVERVIEW
23.13.2 REVENUE ANALYSIS
23.13.3 GEOGRAPHIC PRESENCE
23.13.4 PRODUCT PORTFOLIO
23.13.5 RECENT DEVELOPMENTS
23.14 PLANMECA
23.14.1 COMPANY OVERVIEW
23.14.2 REVENUE ANALYSIS
23.14.3 GEOGRAPHIC PRESENCE
23.14.4 PRODUCT PORTFOLIO
23.14.5 RECENT DEVELOPMENTS
24 RELATED REPORTS
25 QUESTIONNAIRE
26 ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
